Novartis AG 

(Public, VTX:NOVN)     
Find more results for NOVN

Officers and directors

Daniel L. Vasella M.D.
Chairman of the Board, Chief Executive Officer
Joseph Jimenez
CEO - Pharmaceuticals Division
Joerg Reinhardt Ph.D.
Chief Operating Officer
Thomas Werlen Ph.D.
General Counsel
Juergen Brokatzky-Geiger
Head - Human Resources
Mark C. Fishman M.D.
Member - Executive Committee
Andreas Rummelt Ph.D.
Group Head - Quality Assurance and Technical Operations
Thomas Wellauer Ph.D.
Head - Corporate Affairs
Jonathan R. Symonds
Deputy Chief Financial Officer
Ulrich Lehner Ph.D.
Independent Non-Executive Vice Chairman of the Board, Lead Director

Address

Lichtstrasse 35
Basel, 4022
Switzerland

Website links

Novartis AG is a Switzerland-based holding that, through its subsidiaries, is engaged in the research, development, manufacture and marketing of healthcare products. The Company’s healthcare solutions portfolio includes medicines, preventive vaccines and diagnostic tools, generic pharmaceuticals and consumer health products. Its businesses are divided on a worldwide basis into \ four operating divisions: Pharmaceuticals, which comprises brand-name patented pharmaceuticals; Vaccines and Diagnostics, which focuses on human vaccines and blood-testing diagnostics; Sandoz, which consists generic pharmaceuticals, and Consumer Health, which includes over-the-counter medicines, animal health medicines, and contact lenses and lens-care products. It operates in approximately 140 countries. In September 2009, Novartis AG announced that its Sandoz division has completed the acquisition of EBEWE Pharma's specialty generic injectables business.

Novartis AG discussions

  View all discussions »

Related companies

* Delayed by up to 20 minutes -  Disclaimer